A non-invasive wearable sampler combined with UHPLC–IMS-HRMS has been developed to identify biomarkers for TB using human ...

A research team is developing a 3D-printed skin imitation equipped with living cells in order to test nanoparticles from cosmetics without animal testing. A research team from TU Graz and the ...

Dr. Kayvan Zainabadi (center) is working with colleagues in Pune, India, to test the RNA-based TB diagnostic he is developing. From left: Dr. Mandar Paradkar (co-PI, pediatrician), Vidyulata ...

Tuberculosis (TB), caused by the bacterium Mycobacterium tuberculosis, was responsible for 1.25 million deaths in 2023, 13% of which were among people living with HIV. Currently, the main ...

Much like GeneXpert and Truenat, the rt-LAMP assay too is a molecular test with high sensitivity and specificity. The rt-LAMP assay was able to detect TB DNA even when only 10 copy numbers were ...

Initiatives under this partnership include Non-Invasive Prenatal Testing (NIPT ... for Tuberculosis (TB) significantly impacting India’s healthcare landscape where roughly 26% of Global TB ...

"So allergy prick testing is a type of allergy skin test that we perform in office to help identify triggers of different seasonal or environmental allergy symptoms," said Skye Miller, UPMC ...

Perspective from Jay A. Lieberman, MD Reaction severity and skin prick testing results predicted persistent sesame allergy among children, according to a study published in Pediatric Allergy and ...

Using the new test, an analysis of hundreds of blood plasma samples taken from stage III melanoma patients with mutated BRAF genes -- who make up about half of all skin cancer sufferers ...

We compared the specificity and sensitivity of the tuberculin skin test (TST) and the IGRA for LTBI and conducted a random effects meta-analysis on sensitivity of the IGRA for TB disease.

Day on March 24 was started to create awareness among people about a chronic, sinister but totally curable disease. Before, T.B. was considered a death warrant. But the discovery of the first anti-TB.